acquired
Stage
2015
Founded
1
Investors
About
Prexton Therapeutics was a biopharmaceutical company focused on developing novel therapeutic compounds for central nervous system (CNS) disorders, with a primary focus on Parkinson's disease.
Explore Prexton Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.